Your browser doesn't support javascript.
loading
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.
De Stefano, Nicola; Giorgio, Antonio; Battaglini, Marco; De Leucio, Alessandro; Hicking, Christine; Dangond, Fernando; Giovannoni, Gavin; Sormani, Maria Pia.
Afiliação
  • De Stefano N; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Giorgio A; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Battaglini M; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • De Leucio A; Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Hicking C; Global Biostatistics, Merck KGaA, Darmstadt, Germany.
  • Dangond F; Global Clinical Development, EMD Serono, Inc., Billerica, MA, USA.
  • Giovannoni G; Department of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Sormani MP; Biostatistics Unit, Department of Health Sciences, University of Genoa, Genoa, Italy.
Mult Scler ; 24(2): 222-226, 2018 02.
Article em En | MEDLINE | ID: mdl-28140753

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article